Dr. Michael L. Arvanitis, MD

Dr. Arvanitis practices at Central Jersey Specialty Surgical Associates in Eatontown, New Jersey.

Dr. Arvanitis' NPI, 1144243684, was assigned on July 25, 2006. Dr. Arvanitis graduated from Drexel University College Of Medicine in 1982. Dr. Arvanitis holds New Jersey license MA51693.

Dr. Arvanitis' primary practice is Central Jersey Specialty Surgical Associates, at 10 Industrial Way E Suite 104 Suite 104, Eatontown, NJ 07724-3333. The practice phone is (732) 389-1331.

Dr. Arvanitis' primary practice is Central Jersey Specialty Surgical Associates in Eatontown, New Jersey. Dr. Arvanitis is also affiliated with Jersey Shore University Medical Center. The medical group on file is Central Jersey Specialty Surgical Associates. Dmand AI also links Dr. Arvanitis to 2 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arvanitis practices, 6 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Arvanitis' primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Arvanitis is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Arvanitis' licenses on file in 2 states: New Jersey and Florida.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Arvanitis treats.

CMS data shows 601 Medicare services from Dr. Arvanitis across 13 procedure codes in 2024, for 271 Medicare patients. Medicare paid $63,747 for them.

CMS counts 271 Medicare patients who saw Dr. Arvanitis in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Arvanitis' median patient age at 65, with 50% women.

In 2024, Dr. Arvanitis wrote 328 Medicare Part D claims for 102 patients. 81% of them were for generic drugs. CMS names the drug for 204 of them, across 9 drugs with 11 or more claims each, at $19,779 in total drug cost. In 2023, CMS named 148 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 68 out of 100 for Dr. Arvanitis for performance year 2024, reported as part of a group. Dr. Arvanitis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 94 procedures of colonoscopy by Dr. Arvanitis, more than 78% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Arvanitis, published from 2013 to 2018. Dr. Arvanitis' most frequent co-authors are Roy M. Dressner, DO, Bogdan Protyniak, FACS, MD and Andrew I. Elkwood, MD.

CMS Open Payments shows 46 general payments to Dr. Arvanitis from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Medtronic USA, Inc. paid the most, $2,436.

Dmand AI lists 7 awards for Dr. Arvanitis, most recently New Jersey Monthly Top Doctors Award in 2019.

Dr. Arvanitis graduated from Drexel University College Of Medicine in 1982. Dr. Arvanitis is a member of ACS and ASCRS.

Dr. Arvanitis is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.